World's Best Scientists 2026 revealed!
Guntram Schernthaner

Guntram Schernthaner

D-Index & Metrics

Medicine

D-Index
77
Citations
26248
World Ranking
18315
National Ranking
101

Overview

Guntram Schernthaner is affiliated with the Medical University of Vienna in Austria. Their research primarily focuses on the field of Medicine, with a special concentration on Endocrinology, Diabetes and Metabolism. Over time, they have contributed to a range of topics related to diabetes treatment, pancreatic function, and metabolic disorders.

The scientist's work spans several key topics including:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Hormonal Regulation and Hypertension
  • Diabetes and associated disorders
  • Diet and metabolism studies
  • Metabolism, Diabetes, and Cancer

Frequent co-authors collaborating with Schernthaner are:

  • Peter Rossing
  • Stefan D. Anker
  • Bertram Pitt
  • Luís M. Ruilope
  • Juliana C.N. Chan

Common publication venues for Schernthaner's research include:

  • Wiener klinische Wochenschrift (4 publications)
  • Diabetes Care (3 publications)
  • Cardiovascular Diabetology (2 publications)
  • Diabetes Obesity and Metabolism (2 publications)
  • Kidney International Reports (1 publication)

Selected recent research papers authored or co-authored by Guntram Schernthaner are:

  • Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes, 2020, Cardiovascular Diabetology
  • Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy, 2021, Kidney International Reports
  • Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure, 2022, Metabolism
  • Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study, 2022, Diabetes Care
  • Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes, 2023, Annals of Internal Medicine

Best Publications

  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    John A. Dormandy;Bernard Charbonnel;David J A Eckland;Erland Erdmann

  • Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

    John B Buse;Michael Nauck;Thomas Forst;Wayne H.H. Sheu

  • Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea A 52-week randomized trial

    Guntram Schernthaner;Jorge Luiz Gross;Julio Rosenstock;Michael Guarisco

  • Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

    Jürgen Floege;Joseph Kim;Elizabeth Ireland;Charles Chazot

  • A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

    J. Rosenstock;M. Davies;P. D. Home;J. Larsen

  • Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

    H.P. Kopp;C.W. Kopp;A. Festa;K. Krzyzanowska

  • Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease

    Gavin J. Becker;David C. Wheeler;Dick De Zeeuw;Toshiro Fujita

  • Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes

    Alan Sinclair;John E. Morley;Leo Rodriguez-Mañas;Giuseppe Paolisso

  • Hypoglycemia and Cardiovascular Risks

    Brian M. Frier;Guntram Schernthaner;Simon R. Heller

  • Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial

    G. Schernthaner;D. R. Matthews;B. Charbonnel;M. Hanefeld

  • Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

    Mohammed I. Hawa;Hubert Kolb;Nanette Schloot;Huriya Beyan

  • Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months.

    I Mühlhauser;V Jörgens;M Berger;W Graninger

  • One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

    Markolf Hanefeld;Paolo Brunetti;Guntram H Schernthaner;David R Matthews

  • Immunogenicity and Allergenic Potential of Animal and Human Insulins

    Guntram Schernthaner

  • Decreased vascular prostacyclin in juvenile-onset diabetes.

    K Silberbauer;G Schernthaner;H Sinzinger;H Piza-Katzer

  • Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

    J.E. Banatvala;G. Schernthaner;E. Schober;L.M. De Silva

  • Increased visfatin concentrations in women with gestational diabetes mellitus.

    Katarzyna Krzyzanowska;Walter Krugluger;Friedrich Mittermayer;Rupa Rahman

  • Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women

    H.-P. Kopp;K. Krzyzanowska;M. Möhlig;J. Spranger

  • Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515

    G Schernthaner;JL Gross;J Rosenstock;M Guarisco

  • For Training Purposes Only Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

    Guntram Schernthaner;Jorge L. Gross;Julio Rosenstock;Michael Guarisco

Frequent Co-Authors

Heinz Ludwig
Heinz Ludwig University of Vienna
Paolo Pozzilli
Paolo Pozzilli Università Campus Bio-Medico
Hubert Kolb
Hubert Kolb Heinrich Heine University Düsseldorf
Michael Roden
Michael Roden Heinrich Heine University Düsseldorf
Per-Henrik Groop
Per-Henrik Groop University of Helsinki
Hans-Juergen Woerle
Hans-Juergen Woerle Nestlé (Switzerland)
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
André Scheen
André Scheen University of Liège
Vlado Perkovic
Vlado Perkovic George Institute for Global Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of online degrees and careers in healthcare. For those looking to enter the workforce quickly, accelerated lpn program options offer a fast route into practical nursing with flexible online coursework. Graduates can start their medical careers sooner while balancing other commitments.

Nurses seeking to specialize in mental health may consider the fastest psychiatric nurse practitioner program to advance their qualifications and provide specialized care. These accelerated programs can lead to leadership roles in psychiatric healthcare and are ideal for professionals ready to quickly upskill.

Not all healthcare careers involve direct patient care. Those interested in management or administrative roles can benefit from a health care administration online degree. These programs equip students with the skills to oversee healthcare facilities efficiently. For further advancement, an online mha programs affordable option provides an economical way to earn a master’s in healthcare administration, expanding career opportunities even further.

Best Scientists Citing Guntram Schernthaner

Trending Scientists